R-Pharm Import-Substitutes German Erbitux — Drug for Head and Neck Cancer Therapy
The Ministry of Health of the Russian Federation has...
Petrovax Pharm Investments in Meningitis Vaccine Production Exceed 3 Billion Rubles
Biopharmaceutical company Petrovax Pharm has announced receiving an expanded...
Ellara Prepares to Launch Unique Peptide Synthesis Facility
Pharmaceutical company Ellara is completing preparations for the opening...
GMP Registry: New Certificates Issued and Refusals in January 2026
On January 26, the Ministry of Industry and Trade...
First Issued GMP Certificates and Refusals in 2026
January 2026 was marked by high regulatory activity: the...
2025’s Top 10 Clinical Trial Flops in Global Pharma
Clinical trials are always high-stakes gambles. 2025 has been...
Trump Launches TrumpRx: A Blow to Big Pharma or Pre-Election Hype?
President Donald Trump officially launched the TrumpRx.gov platform on...
WHO Issues Global Guidelines on the Use of “Weight Loss Shots”
The World Health Organization (WHO) has for the first...
Big Pharma Companies Expand in China: Investment Overview for 2026
By 2026, China is completing its transformation from a...
EU Adopts New Mandatory GMP Regulations for Veterinary Medicinal Products
In October 2025, the European Commission published new Implementing...
Rospotrebnadzor Cleans Up the Web: 3,000 Resources with Dangerous Dietary Supplements Blocked
The Federal Service for Surveillance on Consumer Rights Protection...
Automated Fines for Expired Dietary Supplements to Start March 1 for Pharmacies
The dietary supplement (BAA) market will be the first...
EMA and PIC/S Tighten Control Over Active Pharmaceutical Substance Production
The European Medicines Agency (EMA), in collaboration with the...
What Happens in 2031? Regulator Sets “Deadline” for EAEU Veterinary Drug Rules
Since March 2024, supranational rules for the circulation of...
Transition to EAEU Standards: GMP Certification Rules for Veterinary Drugs are Changing
A draft Decree of the Government of the Russian...
SUSU Scientists Synthesize a Selective Anti-Anxiety Molecule
Researchers at South Ural State University (SUSU) have discovered...
Neural Network Breakthrough: FDA Approves Trials for AI-Created Parkinson’s Drug
January 23, 2026, became a landmark date for digital...
Good AI Practice: EMA and FDA Establish 10 Global Principles
Global regulators are setting a unified standard for the...
Eli Lilly and NVIDIA Open $1B AI R&D Center for Molecule Generation
Eli Lilly and NVIDIA have announced a major partnership...
OpenAI Enters Healthcare Market with ChatGPT Health and Enterprise Clinical Platform
OpenAI has officially announced its expansion into the healthcare...
R-Pharm Import-Substitutes German Erbitux — Drug for Head and Neck Cancer Therapy
The Ministry of Health of the Russian Federation has...
Petrovax Pharm Investments in Meningitis Vaccine Production Exceed 3 Billion Rubles
Biopharmaceutical company Petrovax Pharm has announced receiving an expanded...
Ellara Prepares to Launch Unique Peptide Synthesis Facility
Pharmaceutical company Ellara is completing preparations for the opening...
GMP Registry: New Certificates Issued and Refusals in January 2026
On January 26, the Ministry of Industry and Trade...
First Issued GMP Certificates and Refusals in 2026
January 2026 was marked by high regulatory activity: the...
2025’s Top 10 Clinical Trial Flops in Global Pharma
Clinical trials are always high-stakes gambles. 2025 has been...
Trump Launches TrumpRx: A Blow to Big Pharma or Pre-Election Hype?
President Donald Trump officially launched the TrumpRx.gov platform on...
WHO Issues Global Guidelines on the Use of “Weight Loss Shots”
The World Health Organization (WHO) has for the first...
Big Pharma Companies Expand in China: Investment Overview for 2026
By 2026, China is completing its transformation from a...
EU Adopts New Mandatory GMP Regulations for Veterinary Medicinal Products
In October 2025, the European Commission published new Implementing...
Rospotrebnadzor Cleans Up the Web: 3,000 Resources with Dangerous Dietary Supplements Blocked
The Federal Service for Surveillance on Consumer Rights Protection...
Automated Fines for Expired Dietary Supplements to Start March 1 for Pharmacies
The dietary supplement (BAA) market will be the first...
EMA and PIC/S Tighten Control Over Active Pharmaceutical Substance Production
The European Medicines Agency (EMA), in collaboration with the...
What Happens in 2031? Regulator Sets “Deadline” for EAEU Veterinary Drug Rules
Since March 2024, supranational rules for the circulation of...
Transition to EAEU Standards: GMP Certification Rules for Veterinary Drugs are Changing
A draft Decree of the Government of the Russian...
SUSU Scientists Synthesize a Selective Anti-Anxiety Molecule
Researchers at South Ural State University (SUSU) have discovered...
Neural Network Breakthrough: FDA Approves Trials for AI-Created Parkinson’s Drug
January 23, 2026, became a landmark date for digital...
Good AI Practice: EMA and FDA Establish 10 Global Principles
Global regulators are setting a unified standard for the...
Eli Lilly and NVIDIA Open $1B AI R&D Center for Molecule Generation
Eli Lilly and NVIDIA have announced a major partnership...
OpenAI Enters Healthcare Market with ChatGPT Health and Enterprise Clinical Platform
OpenAI has officially announced its expansion into the healthcare...
PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).
Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.
Headlines
Amedart to Launch Biotechnological Substance Production in Moscow: Investments Exceed 800 Million Rubles
The capital's pharmaceutical industry has received a new impetus...
Rospotrebnadzor Cleans Up the Web: 3,000 Resources with Dangerous Dietary Supplements Blocked
The Federal Service for Surveillance on Consumer Rights Protection...
GMP Registry Update: New Certificate Issuances by February 13, 2026
The Ministry of Industry and Trade of the Russian...
Price War in the Weight Loss Market: PROMOMED Cuts Tirzetta Cost Following GEROPHARM
The Russian market for obesity and diabetes therapies has...
